M
Muluye E. Liku
Researcher at University of California, San Francisco
Publications - 4
Citations - 367
Muluye E. Liku is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Cyclin-dependent kinase & Induced pluripotent stem cell. The author has an hindex of 4, co-authored 4 publications receiving 336 citations.
Papers
More filters
Journal ArticleDOI
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma
Guido von Figura,Akihisa Fukuda,Nilotpal Roy,Muluye E. Liku,John P. Morris,Grace E. Kim,Holger A. Russ,Matthew A. Firpo,Sean J. Mulvihill,David W. Dawson,Jorge Ferrer,William F. Mueller,Anke Busch,Klemens J. Hertel,Matthias Hebrok +14 more
TL;DR: This study implicates Brg1 as a determinant of context-dependent Kras-driven pancreatic tumorigenesis and suggests that chromatin remodelling may underlie the development of distinct PDA subsets.
Journal ArticleDOI
CDK phosphorylation of a novel NLS-NES module distributed between two subunits of the Mcm2-7 complex prevents chromosomal rereplication.
TL;DR: It is speculated that the distribution of partial transport signals among distinct subunits of a complex may enhance the specificity of protein localization and raises the possibility that previously undetected distributed transport signals are used by other multiprotein complexes.
Journal ArticleDOI
Regulatory evolution in proteins by turnover and lineage-specific changes of cyclin-dependent kinase consensus sites.
TL;DR: It is suggested that the CDK regulation of MCM nuclear localization was acquired in the lineage leading to Saccharomyces cerevisiae after the divergence with Candida albicans, and the presence or absence of the cluster of sites in different species is associated with differential regulation of the transport signal.
Book ChapterDOI
Directed differentiation of human pluripotent stem cells along the pancreatic endocrine lineage.
Dennis Van Hoof,Muluye E. Liku +1 more
TL;DR: The protocol, which spans five distinct stages, is an attempt to recapitulate the derivation of pancreatic β-cells in vitro as they form in the developing embryo.